Skip to main content
. 2012 Feb 1;5(1):10–18. doi: 10.1593/tlo.11208

Table 2.

Differences of Metabolic and Diffusion Parameters between AAs, OD3s, and OA3s.

Parameter Percentile NE Lesion CE Lesion CNI2–3 CNI3–4 CNI > 4
nNAA 25th P = .035 (AA = 0.34, OD3 = 0.19)
LL/NAA 50th (median) P = .034 (AA = 0.04, OD3 = 0.08) P = .05 (AA = 0.07, OD3 = 0.20) P = .012 (AA = 0.08, OD3 = 0.16)
75th P = .013 (AA = 0.11, OD3 = 0.17) P = .022 (AA = 0.14, OD3 = 0.29) P = .034 (AA = 0.10, OD3 = 0.15) P = .03 (AA = 0.11, OD3 = 0.20) P = .018 (AA = 0.15, OD3 = 0.20)
P = .048 (OD3 = 0.17, OA3 = 0.11) P = .023 (OD3 = 0.15, OA3 = 0.08) P = .007 (OD3 = 0.20, OA3 = 0.10)
90th P = .023 (AA = 0.18, OD3 = 0.24) P = .035 (AA = 0.27, OD3 = 0.33) P = .034 (AA = 0.15, OD3 = 0.21) P = .015 (AA = 0.16, OD3 = 0.27)
P = .018 (OD3 = 0.21, OA3 = 0.13) P = .017 (OD3 = 0.27, OA3 = 0.14)
Lac 50th (median) P = .036* (OA3 = 3.66, OD3 = 3.50) P = .03* (AA = 2.18, OD3 = 3.68)

P values were calculated with the Mann-Whitney rank sum test. Only the values that significantly differed between the grade 3 glioma subtypes are reported in this table.

*

There were only three patients with OD3 who had lactate-edited MRSI with visible lactate peaks, and so these differences were not considered significant.